Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Matinas BioPharma Announces Results From An Additional In Vivo Study In Healthy Mice With An Oral LNC Formulation Of Docetaxel, A Chemotherapeutic Agent Used In The Management Of Multiple Metastatic And Unresectable Tumors

Author: Benzinga Newsdesk | March 25, 2024 08:16am

Posted In: MTNB